Phibro Animal Health
Phibro Animal Health Corporation is an American multinational animal health, nutrition, and biopharmaceutical enterprise specializing in the research, development, production, and global wholesale distribution of animal health products, medicated feed additives, vaccines, nutritional specialty additives, and performance enhancers designed to improve animal health and productivity for livestock, poultry, and aquaculture producers across the United States and more than 65 international export markets. Operating advanced fermentation and chemical synthesis manufacturing plants, the company is a pioneer in global animal health solutions. Its core business operations encompass veterinary medicinal product manufacturing, animal nutrition additive production, vaccine research, and international wholesale distribution. Revenue is derived directly from the commercial wholesale sale of animal health products, medicated feed additives, and specialty nutrition compounds. Phibro Animal Health holds a leading global market position in animal health and nutritional feed additives. The company is headquartered in Teaneck, New Jersey, United States, and its common stock trades on the Nasdaq Global Select Market under the ticker PAHC.
4 of the funds FundTelligence covers report a position in Phibro Animal Health.
- Legal name
- Phibro Animal Health Corp
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 4
- Exposure themes
- Agricultural Technology & Inputs, Food & Agriculture Transformation, Inputs & Biologicals
Funds holding Phibro Animal Health
- Simplicity Småbolag Global — Simplicity · 0.63 % (full portfolio disclosed, June 2026)
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.04 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)